Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:09 PM
Ignite Modification Date:
2025-12-24 @ 11:09 PM
NCT ID:
NCT06999369
Eligibility Criteria:
Inclusion Criteria:
* 18-89 years old at time of enrollment
* Any type of Heart failure diagnosis (e.g., I50.x) between 1/1/2023-present
* Recent hospital admission (within a year)
* Race/ethnicity: All race/ethnic groups
* Location: patients have been treated in the Greater East Bay division and Greater Silicon Valley division areas.
* Patients with have at least 1 office/outpatient visit with a primary care physician or cardiologist visit before index date
Exclusion Criteria:
* • Patients with certain patient history (cognitive disabilities) and end stage renal or metastatic cancer diagnosis
* Patients with active drug/substance use. Patients with heart failure who have active substance use are excluded from the study. HF patients with substance use require additional monitoring and follow up due to potential severe withdrawal symptoms, acute HF exacerbation and drug overdose or medication errors. Standard protocol includes additional monitor vital signs (e.g., blood pressure, heart rate) and HF symptoms (e.g., edema, dyspnea), and performing regular laboratory tests (e.g., renal function, electrolytes) which is beyond the clinical and logistical capabilities of this study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
89 Years
Study:
NCT06999369
Study Brief:
Protocol Section:
NCT06999369